Evidence map›Paper›PMID 26440593›Full record

ArticleAmerican journal of infection control2016

Impact of rapid screening for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions.

Erica S Shenoy, Hang Lee, Jessica A Cotter, Winston Ware, Douglas Kelbaugh, Eric Weil, Rochelle P Walensky, David C Hooper

Abstract read
In one paragraph

Article in American journal of infection control, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Effectiveness of preoperative decolonization with nasal povidone iodine in Chinese patients undergoing elective orthopedic surgery: a prospective cross-sectional study.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2017
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Erica S ShenoyHarvard Medical School, Boston, MA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA; Infection Control Unit, Massachusetts General Hospital, Boston, MA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA. Electronic address: eshenoy@partners.org.
Hang LeeDepartment of Biostatistics, Massachusetts General Hospital, Boston, MA.
Jessica A CotterInfection Control Unit, Massachusetts General Hospital, Boston, MA.
Winston WareClinical Care Management Unit, Massachusetts General Hospital, Boston, MA.
Douglas KelbaughPartners Information Systems, Massachusetts General Hospital and Massachusetts General Physicians Organization, Boston, MA.
Eric WeilDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA; Massachusetts General Physicians Organization.
Rochelle P WalenskyHarvard Medical School, Boston, MA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA.
David C HooperHarvard Medical School, Boston, MA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA; Infection Control Unit, Massachusetts General Hospital, Boston, MA. Electronic address: dhooper@mgh.harvard.edu.

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Harvard Clinical and Translational Science Center (KL2)KL2RR025757 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$4.1M
Improving clinical, operational and economic outcomes related to MRSAK01AI110524 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SHENOY, ERICA SEIGUER · 2014 to 2016
$411k
NCATS NIH HHS UL1 TR001102NCATS NIH HHS UL1TR001102NCRR NIH HHS KL2 RR025757NCRR NIH HHS KL2 RR025757-03NIAID NIH HHS K01 AI110524NIAID NIH HHS K01AI110524NIAID NIH HHS T32 AI007061
6 · The paper itself

Abstract

backgroundA history of methicillin-resistant Staphylococcus aureus (MRSA) is a determinant of inpatient bed assignment.

methodsWe assessed outcomes associated with rapid testing and discontinuation of MRSA contact precautions (CP) in a prospective cohort study of polymerase chain reaction (PCR)-based screening in the Emergency Department (ED) of Massachusetts General Hospital. Eligible patients had a history of MRSA and were assessed and enrolled if documented off antibiotics with activity against MRSA and screened for nasal colonization (subject visit). PCR-negative subjects had CP discontinued; the primary outcome was CP discontinuation. We identified semiprivate rooms in which a bed was vacant owing to the CP status of the study subject, calculated the hours of vacancy, and compared idle bed-hours by PCR results. Program costs were compared with predicted revenue.

resultsThere were 2864 eligible patients, and 648 (22.6%) subject visits were enrolled. Of these, 65.1% (422/648) were PCR-negative and had CP discontinued. PCR-negative subjects had fewer idle bed-hours compared with PCR-positive subjects (28.6 ± 25.2 vs 75.3 ± 70.5; P < .001). The expected revenues from occupied idle beds and averted CP costs ranged from $214,160 to $268,340, and exceeded the program costs.

conclusionA program of targeted PCR-based screening for clearance of MRSA colonization resulted in expected revenues and decreased CP costs that outweighed programmatic costs.

Indexed as

Infection ControlAdultAgedAged, 80 and overCohort StudiesCost-Benefit AnalysisCross InfectionFemaleHumansMaleMassachusettsMethicillin ResistanceMethicillin-Resistant Staphylococcus aureusMiddle AgedNosePilot ProjectsContact precautionsCostsImplementationMRSA

Identifiers

PMID26440593
PMCPMC4728016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.